This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 3 riesgos adicionales
Competidores de Tricida, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.00001 |
| 52 Week High | US$13.85 |
| 52 Week Low | US$0.00001 |
| Beta | 0.051 |
| 1 Month Change | -99.89% |
| 3 Month Change | -99.93% |
| 1 Year Change | -100.00% |
| 3 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Noticias y actualizaciones recientes
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14
Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29Rentabilidad de los accionistas
| TCDA.Q | US Pharmaceuticals | Mercado US | |
|---|---|---|---|
| 7D | -99.9% | 2.3% | 1.6% |
| 1Y | -100.0% | 10.8% | 25.1% |
Rentabilidad vs. Industria: TCDA.Q underperformed the US Pharmaceuticals industry which returned 6.4% over the past year.
Rentabilidad vs. Mercado: TCDA.Q underperformed the US Market which returned 14% over the past year.
Volatilidad de los precios
| TCDA.Q volatility | |
|---|---|
| TCDA.Q Average Weekly Movement | 43.8% |
| Pharmaceuticals Industry Average Movement | 10.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: TCDA.Q's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: TCDA.Q's weekly volatility has increased from 31% to 44% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2013 | 57 | Gerrit Klaerner | www.tricida.com |
Resumen de fundamentos de Tricida, Inc.
| Estadísticas fundamentales de TCDA.Q | |
|---|---|
| Capitalización bursátil | US$580.00 |
| Beneficios(TTM) | -US$133.91m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está TCDA.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de TCDA.Q | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$133.91m |
| Beneficios | -US$133.91m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -2.31 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | -143.5% |
¿Cómo se ha desempeñado TCDA.Q a largo plazo?
Ver rendimiento histórico y comparativa